May 12, 2017 Is International ME/CFS and FM Awareness Day
International ME/CFS and FM Awareness Day is May 12th, 2017. Jody Smith shares some information about upcoming events and ways you can be heard ...
Discuss the article on the Forums.

KL1333, orphan drug approved for the treatment of mitochondrial disorders

Discussion in 'Other Health News and Research' started by Ema, May 4, 2018.

  1. Ema

    Ema Senior Member

    Messages:
    4,588
    Likes:
    6,622
    Midwest USA
    “KL1333 is a potent regulator of the cellular levels of NAD+, a key molecule in the cell’s energy metabolism. In preclinical studies, KL1333 was able to increase mitochondrial energy levels, reduce the formation and accumulation of toxic compounds (e.g., lactate and free radicals), and induce the formation of new mitochondria.”

    https://mitochondrialdiseasenews.co...rphan-drug-status-mitochondrial-diseases/?amp
     
    Mary, junkcrap50, alkt and 2 others like this.
  2. nanonug

    nanonug Senior Member

    Messages:
    1,664
    Likes:
    1,104
    Virginia, USA
    Awesome! Looking forward to put my hands on this when available.
     
    Ema and alkt like this.
  3. HowToEscape?

    HowToEscape? Senior Member

    Messages:
    540
    Likes:
    724
    A pre-clinical study is a long way from proof that this stuff is effective for the treatment of any disease, much less one one understands. Hope it pans out, don’t hold your breath.
     

See more popular forum discussions.

Share This Page